Research and Clinical Trials

Title  

COG ACNS0831: Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years

Brief Description  

This randomized phase III trial is studying maintenance chemotherapy to see how well it works compared to observation following induction chemotherapy and radiation therapy in treating young patients with newly diagnosed ependymoma.

Who may be Eligible  

Please contact us for eligibility criteria.

Speciality/Disorder  

Brain and Nervous System

Status  

OPEN

Start Date  

05/18/2010

IRB Number  

05-10-06B

Principal Investigator  

Kaplan, Joel Adam

Contact Name  

Sceria Jenkins

For More Information, Contact  Sceria  , Jenkins
Phone:  980-442-2323 Fax:    
Email:  sceria.jenkins@atriumhealth.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204